900P - Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data
| Autor: | Bjarnason, G.A., Knox, J., Kollmannsberger, C.K., Soulieres, D., Ernst, D.S., Zalewski, P., Canil, C.M., Winquist, E., Hotte, S.J., North, S.A., Heng, D.Y.C., Macfarlane, R.J., Venner, P.M., Kapoor, A., Hansen, A.R., Czaykowski, P., Boyd, B., Wang, L., Basappa, N.S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v319-v319 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|